220 related articles for article (PubMed ID: 35691995)
1. Changes in software as a medical device based on artificial intelligence technologies.
Zinchenko V; Chetverikov S; Akhmad E; Arzamasov K; Vladzymyrskyy A; Andreychenko A; Morozov S
Int J Comput Assist Radiol Surg; 2022 Oct; 17(10):1969-1977. PubMed ID: 35691995
[TBL] [Abstract][Full Text] [Related]
2. Minimum labelling requirements for dermatology artificial intelligence-based Software as Medical Device (SaMD): A consensus statement.
Ingvar Å; Oloruntoba A; Sashindranath M; Miller R; Soyer HP; Guitera P; Caccetta T; Shumack S; Abbott L; Arnold C; Lawn C; Button-Sloan A; Janda M; Mar V
Australas J Dermatol; 2024 May; 65(3):e21-e29. PubMed ID: 38419186
[TBL] [Abstract][Full Text] [Related]
3. The current status of breakthrough devices designation in the United States and innovative medical devices designation in Korea for digital health software.
Woo JH; Kim EC; Kim SM
Expert Rev Med Devices; 2022 Mar; 19(3):213-228. PubMed ID: 35255755
[TBL] [Abstract][Full Text] [Related]
4. Technology-Enabled, Evidence-Driven, and Patient-Centered: The Way Forward for Regulating Software as a Medical Device.
Carolan JE; McGonigle J; Dennis A; Lorgelly P; Banerjee A
JMIR Med Inform; 2022 Jan; 10(1):e34038. PubMed ID: 35084352
[TBL] [Abstract][Full Text] [Related]
5. Artificial intelligence (AI) impacting diagnosis of glaucoma and understanding the regulatory aspects of AI-based software as medical device.
Prabhakar B; Singh RK; Yadav KS
Comput Med Imaging Graph; 2021 Jan; 87():101818. PubMed ID: 33307283
[TBL] [Abstract][Full Text] [Related]
6. Examining labelling guidelines for AI-based software as a medical device: A review and analysis of dermatology mobile applications in Australia.
Oloruntoba A; Ingvar Å; Sashindranath M; Anthony O; Abbott L; Guitera P; Caccetta T; Janda M; Soyer HP; Mar V
Australas J Dermatol; 2024 May; ():. PubMed ID: 38693690
[TBL] [Abstract][Full Text] [Related]
7. Innovation Process and Industrial System of US Food and Drug Administration-Approved Software as a Medical Device: Review and Content Analysis.
Yu J; Zhang J; Sengoku S
J Med Internet Res; 2023 Nov; 25():e47505. PubMed ID: 37999948
[TBL] [Abstract][Full Text] [Related]
8. The need for a system view to regulate artificial intelligence/machine learning-based software as medical device.
Gerke S; Babic B; Evgeniou T; Cohen IG
NPJ Digit Med; 2020; 3():53. PubMed ID: 32285013
[TBL] [Abstract][Full Text] [Related]
9. ARTIFICIAL INTELLIGENCE IN MEDICAL PRACTICE: REGULATIVE ISSUES AND PERSPECTIVES.
Pashkov VM; Harkusha AO; Harkusha YO
Wiad Lek; 2020; 73(12 cz 2):2722-2727. PubMed ID: 33611272
[TBL] [Abstract][Full Text] [Related]
10. Clinical Simulation in the Regulation of Software as a Medical Device: An eDelphi Study.
O'Driscoll F; O'Brien N; Guo C; Prime M; Darzi A; Ghafur S
JMIR Form Res; 2024 Jun; 8():e56241. PubMed ID: 38917454
[TBL] [Abstract][Full Text] [Related]
11. Artificial Intelligence and Machine Learning Applied at the Point of Care.
Angehrn Z; Haldna L; Zandvliet AS; Gil Berglund E; Zeeuw J; Amzal B; Cheung SYA; Polasek TM; Pfister M; Kerbusch T; Heckman NM
Front Pharmacol; 2020; 11():759. PubMed ID: 32625083
[TBL] [Abstract][Full Text] [Related]
12. The EU medical device regulation: Implications for artificial intelligence-based medical device software in medical physics.
Beckers R; Kwade Z; Zanca F
Phys Med; 2021 Mar; 83():1-8. PubMed ID: 33657513
[TBL] [Abstract][Full Text] [Related]
13. Developing a Digital Solution for Remote Assessment in Multiple Sclerosis: From Concept to Software as a Medical Device.
van der Walt A; Butzkueven H; Shin RK; Midaglia L; Capezzuto L; Lindemann M; Davies G; Butler LM; Costantino C; Montalban X
Brain Sci; 2021 Sep; 11(9):. PubMed ID: 34573267
[TBL] [Abstract][Full Text] [Related]
14. Breaking down the silos of artificial intelligence in surgery: glossary of terms.
Moglia A; Georgiou K; Morelli L; Toutouzas K; Satava RM; Cuschieri A
Surg Endosc; 2022 Nov; 36(11):7986-7997. PubMed ID: 35729406
[TBL] [Abstract][Full Text] [Related]
15. Key Principles of Clinical Validation, Device Approval, and Insurance Coverage Decisions of Artificial Intelligence.
Park SH; Choi J; Byeon JS
Korean J Radiol; 2021 Mar; 22(3):442-453. PubMed ID: 33629545
[TBL] [Abstract][Full Text] [Related]
16. Global Regulatory Frameworks for the Use of Artificial Intelligence (AI) in the Healthcare Services Sector.
Palaniappan K; Lin EYT; Vogel S
Healthcare (Basel); 2024 Feb; 12(5):. PubMed ID: 38470673
[TBL] [Abstract][Full Text] [Related]
17. Industry ties and evidence in public comments on the FDA framework for modifications to artificial intelligence/machine learning-based medical devices: a cross sectional study.
Smith JA; Abhari RE; Hussain Z; Heneghan C; Collins GS; Carr AJ
BMJ Open; 2020 Oct; 10(10):e039969. PubMed ID: 33055121
[TBL] [Abstract][Full Text] [Related]
18. Regulatory Aspects of the Use of Artificial Intelligence Medical Software.
Zanca F; Brusasco C; Pesapane F; Kwade Z; Beckers R; Avanzo M
Semin Radiat Oncol; 2022 Oct; 32(4):432-441. PubMed ID: 36202445
[TBL] [Abstract][Full Text] [Related]
19. [Artificial intelligence : A helpful tool for radiologists?].
Schütze B; Schlieter H
Radiologe; 2019 Dec; 59(12):1091-1096. PubMed ID: 31578624
[TBL] [Abstract][Full Text] [Related]
20. AI in imaging: the regulatory landscape.
Hill DLG
Br J Radiol; 2024 Feb; 97(1155):483-491. PubMed ID: 38366148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
